Women scientists and clinicians are creators and changemakers, expanding the boundaries of human knowledge


The Neuro has launched Neuro XXceptional - an exciting new year-long video series featuring women who tell us what drove them to become scientists and clinicians, and what they love about their work. At The Neuro, these exceptional professionals are improving the lives of patients, helping us understand how the brain works and how to treat neurological disease.

Classified as: Neuro XXceptional, women in science, Heidi McBride, Lesley Fellows
Published on: 8 Mar 2018

Industry and academia to share expertise in effort to develop improved methods to produce and characterize antibodies and reagents for neurological research

Classified as: Thermo Fisher, open science, ALS, Parkinson's disease, ataxia, reagrents
Published on: 5 Mar 2018

You’re about to turn 60, and you’re fretting. Your mother has had Alzheimer’s disease since the age of 65. At what age will the disease strike you? A Canadian study published in JAMA Neurology shows that the closer a person gets to the age at which their parent exhibited the first signs of Alzheimer’s, the more likely they are to have amyloid plaques, the cause of the cognitive decline associated with the disease, in their brain.

Classified as: Alzheimer's disease, Alzheimer's
Published on: 26 Feb 2018

Canadian Open Neuroscience Platform will make disseminating and publishing data easier

Modern neuroscience research can produce massive amounts of data, which researchers can use to find patterns revealing anything from the first physiological signs of Alzheimer’s disease to a new drug target that could stop neurodegeneration. However, this data must be stored, processed, and distributed effectively.

Classified as: neuroinformatics, Alan Evans, CONP, Canadian Open Neuroscience Platform, Brain Canada
Published on: 19 Feb 2018

Volume in brain region linked to physiological changes characteristic of AD

New research has drawn a link between changes in the brain’s anatomy and biomarkers that are known to appear at the earliest stages of Alzheimer’s disease (AD), findings that could one day provide a sensitive but non-invasive test for AD before cognitive symptoms appear.

Classified as: Alzheimer's disease, AD, MRI, Christine Tardif, Mallar Chakravarty, Douglas Institute
Published on: 19 Dec 2017

NeuroSGC created to increase volume and quality of cell assays for drug discovery

A new partnership between the Structural Genomics Consortium (SGC) and the Montreal Neurological Institute and Hospital (The Neuro) will use a unique open science framework to help scientists discover new targets for drug development for neurological diseases.

The partnership, called NeuroSGC, will initially focus on Parkinson’s disease and amyotrophic lateral sclerosis (ALS), two of the most common neurodegenerative diseases.

Classified as: open science, MNI
Published on: 6 Dec 2017

Industry and academia team up for the benefit of people suffering from ALS

A unique industry-academia partnership will increase the rate at which promising drug compounds can be tested as potential treatments for amyotrophic lateral sclerosis (ALS), a disease with no known cure that affects 200,000 people worldwide.

The partnership between The Montreal Neurological Institute and Hospital (MNI) and Takeda Pharmaceutical Company Limited (Takeda) will allow compounds developed by Takeda scientists to be tested on cell lines produced at the MNI.

Classified as: Takeda, stem cells, ALS, hiPSCs, amyotrophic lateral sclerosis, open science, C-BIGR, Open Drug Discovery Platform
Published on: 4 Dec 2017

Senate of Canada recognizes outstanding contributions to the community 

The Senate of Canada has awarded Alan Evans a Canada 150 medal for his commitment to advancements in Alzheimer’s disease and palliative care research. He was nominated by Senator Judith Seidman, a former research fellow at the Montreal Neurological Institute and Hospital, and Associate Professor of the McGill School of Social Work.

Classified as: Alan Evans
Published on: 27 Nov 2017

Grants for Heather Durham, Stefano Stifani and Jay Ross total just over $2 million 

Three MNI researchers have received grants from the ALS Society of Canada worth a total of more than $2 million.  

Published on: 24 Nov 2017

Brain stimulation can change how much we enjoy and value music

Enjoyment of music is considered a subjective experience; what one person finds gratifying, another may find irritating. Music theorists have long emphasized that although musical taste is relative, our enjoyment of music, be it classical or heavy metal, arises, among other aspects, from structural features of music, such as chord or rhythm patterns that generate anticipation and expectancy.

Classified as: music, Robert Zatorre, Ernest Mas Herrero, fronto-striatal circuits, TMS, transcranial magnetic stimulation
Published on: 20 Nov 2017

The Azrieli Centre for Autism Research will foster innovations in therapy and a better understanding of Autism Spectrum Disorder.

A new research centre in Montreal will help lift the shroud of mystery surrounding autism spectrum disorder (ASD), and lead to the development of better diagnostic tools and more effective therapies for people with autism.

Classified as: Autism Research, Azrieli Foundation, autism
Published on: 23 Oct 2017

A Brilliant Night has donated a total of $1.6 million since 2015

A night dedicated to the memory of those lost to brain cancer and in honour of those still fighting the disease will raise money for research that will lead to better treatments.

Classified as: a brilliant night, Kevin Petrecca, brain cancer, brain tumour
Published on: 10 Oct 2017

Research shows how the brain’s motor signals sharpen our ability to decipher complex sound flows

Whether it is dancing or just tapping one foot to the beat, we all experience how auditory signals like music can induce movement. Now new research suggests that motor signals in the brain actually sharpen sound perception, and this effect is increased when we move in rhythm with the sound.

Classified as: Motor signals, Sound perception, Benjamin Morillon, Sylvain Baillet
Published on: 5 Oct 2017

Discovery points to possible target for cancer drugs

McGill University researchers have discovered a mechanism through which mitochondria, the energy factory of our body’s cells, play a role in preventing cells from dying when the cells are deprived of nutrients – a finding that points to a potential target for next-generation cancer drugs.

The research, published in Molecular Cell, builds on previous work by McGill professor Nahum Sonenberg, one of the senior authors of the new study.

Classified as: Heidi McBride, mitochondria
Published on: 22 Sep 2017

Research symposium, public education event and ALS walk planned

Multiple events planned for this week will help educate the public about amyotrophic lateral sclerosis (ALS), a devastating disease that still has no cure.

Classified as: ALS research, ALS, ALS awareness, Research symposium, ALS walk, Neuro, Dr. Angela Genge, ALS Society of Quebec
Published on: 13 Sep 2017